The Laboratory for Applied Cancer Research, Head and Neck Center, Department of Otolaryngology Head and Neck Surgery, Clinical Research Institute at Rambam Healthcare Campus, Haifa, Israel.
Technion Integrated Cancer Center, Rappaport Institute of Medicine and Research, Technion, Israel Institute of Technology, Haifa, Israel.
Oncogene. 2019 Jan;38(4):596-608. doi: 10.1038/s41388-018-0458-y. Epub 2018 Aug 31.
Pancreas cancer cells have a tendency to invade along nerves. Such cancerous nerve invasion (CNI) is associated with poor outcome; however, the exact mechanism that drives cancer cells to disseminate along nerves is unknown. Immunohistochemical analysis of human pancreatic ductal adenocarcinoma (PDAC) specimens showed overexpression of the L1 cell adhesion molecule (L1CAM) in cancer cells and in adjacent Schwann cells (SC) in invaded nerves. By modeling the neural microenvironment, we found that L1CAM secreted from SCs acts as a strong chemoattractant to cancer cells, through activation of MAP kinase signaling. L1CAM also upregulated expression of metalloproteinase-2 (MMP-2) and MMP-9 by PDAC cells, through STAT3 activation. Using a transgenic Pdx-1-Cre/KrasG12D /p53R172H (KPC) mouse model, we show that treatment with anti-L1CAM Ab significantly reduces CNI in vivo. We provide evidence of a paracrine response between SCs and cancer cells in the neural niche, which promotes cancer invasion via L1CAM secretion.
胰腺癌癌细胞有沿着神经侵袭的趋势。这种癌性神经侵袭(CNI)与不良预后相关;然而,驱动癌细胞沿着神经扩散的确切机制尚不清楚。对人胰腺导管腺癌(PDAC)标本的免疫组织化学分析显示,癌细胞和侵袭神经中的相邻施万细胞(SC)中 L1 细胞黏附分子(L1CAM)过度表达。通过模拟神经微环境,我们发现 SC 分泌的 L1CAM 通过激活 MAP 激酶信号,作为一种强烈的趋化因子作用于癌细胞。L1CAM 还通过 STAT3 激活,上调 PDAC 细胞表达的基质金属蛋白酶-2(MMP-2)和 MMP-9。使用 Pdx-1-Cre/KrasG12D /p53R172H(KPC)转基因小鼠模型,我们表明,用抗-L1CAM Ab 治疗可显著减少体内的 CNI。我们提供了神经龛中 SC 和癌细胞之间旁分泌反应的证据,该反应通过 L1CAM 分泌促进癌症侵袭。